世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
デジタルセラピューティック市場。世界の産業動向、シェア、サイズ、成長、機会、そして2021-2026年の予測Digital Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026 The global digital therapeutics market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 22% during 2021-2026. Keeping in mind the uncer... もっと見る
サマリーThe global digital therapeutics market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 22% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.Digital therapeutics (DTx) deliver evidence-based therapeutic interventions to patients. They aid in enhancing the existing medical treatments, providing therapy solutions, and reducing reliance on pharmaceuticals using high-quality software programs. They also prevent, manage and treat physical, mental, and behavioral health and find application in diagnosing conditions like Alzheimer’s disease, type II diabetes, and respiratory disorders, such as asthma, gastrointestinal problems, and chronic obstructive pulmonary disease. At present, there is a significant rise in the demand for DTx as they reduce health care costs and support the overall health of patients. Digital Therapeutics Market Trends: The boosting sales of smart devices like mobile phones and tablets, rising internet penetration and the increasing number of healthcare applications are among the major factors strengthening the growth of the market. DTx finds application in a diverse range of neuroscience indications, such as autism spectrum disorder (ASD), attention deficit hyperactivity disorder (ADHD), depression, schizophrenia, and bipolar disease. Additionally, the rising prevalence of chronic diseases like diabetes and obesity, along with the increasing need for controlling costs of healthcare treatments, are supporting the growth of the market. Furthermore, pharmaceutical companies around the world are investing and engaging in strategic partnerships to expand their product portfolio and market reach. They are also focusing on providing patients with information concerning different conditions and subsequent treatments as well as organizing, tracking, and self-managing their diseases. These initiatives undertaken by pharmaceutical companies are anticipated to impel the growth of the market. Key Market Segmentation: IMARC Group provides an analysis of the key trends in each sub-segment of the global digital therapeutics market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on application and end use. Breakup by Application: Diabetes Obesity CVD CNS Disease Respiratory Diseases Smoking Cessation Others Breakup by End Use: Patients Providers Payers Employers Others Breakup by Region: North America United States Canada Asia-Pacific China Japan India South Korea Australia Indonesia Others Europe Germany France United Kingdom Italy Spain Russia Others Latin America Brazil Mexico Others Middle East and Africa Competitive Landscape: The competitive landscape of the industry has also been examined along with the profiles of the key players being 2Morrow Inc., Canary Health Inc., Click Therapeutics Inc., Mango Health Inc. (TrialCard Incorporated), Noom Health Inc., Omada Health Inc., Pear Therapeutics, Inc., Propeller Health (ResMed), Teladoc Health Inc., Voluntis Inc. and WellDoc Inc. Key Questions Answered in This Report: How has the global digital therapeutics market performed so far and how will it perform in the coming years? What has been the impact of COVID-19 on the global digital therapeutics market? What are the key regional markets? What is the breakup of the market based on the application? What is the breakup of the market based on the end use? What are the various stages in the value chain of the industry? What are the key driving factors and challenges in the industry? What is the structure of the global digital therapeutics market and who are the key players? What is the degree of competition in the industry? 目次1 Preface2 Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends 5 Global Digital Therapeutics Market 5.1 Market Overview 5.2 Market Performance 5.3 Impact of COVID-19 5.4 Market Forecast 6 Market Breakup by Application 6.1 Diabetes 6.1.1 Market Trends 6.1.2 Market Forecast 6.2 Obesity 6.2.1 Market Trends 6.2.2 Market Forecast 6.3 CVD 6.3.1 Market Trends 6.3.2 Market Forecast 6.4 CNS Disease 6.4.1 Market Trends 6.4.2 Market Forecast 6.5 Respiratory Diseases 6.5.1 Market Trends 6.5.2 Market Forecast 6.6 Smoking Cessation 6.6.1 Market Trends 6.6.2 Market Forecast 6.7 Others 6.7.1 Market Trends 6.7.2 Market Forecast 7 Market Breakup by End Use 7.1 Patients 7.1.1 Market Trends 7.1.2 Market Forecast 7.2 Providers 7.2.1 Market Trends 7.2.2 Market Forecast 7.3 Payers 7.3.1 Market Trends 7.3.2 Market Forecast 7.4 Employers 7.4.1 Market Trends 7.4.2 Market Forecast 7.5 Others 7.5.1 Market Trends 7.5.2 Market Forecast 8 Market Breakup by Region 8.1 North America 8.1.1 United States 8.1.1.1 Market Trends 8.1.1.2 Market Forecast 8.1.2 Canada 8.1.2.1 Market Trends 8.1.2.2 Market Forecast 8.2 Asia-Pacific 8.2.1 China 8.2.1.1 Market Trends 8.2.1.2 Market Forecast 8.2.2 Japan 8.2.2.1 Market Trends 8.2.2.2 Market Forecast 8.2.3 India 8.2.3.1 Market Trends 8.2.3.2 Market Forecast 8.2.4 South Korea 8.2.4.1 Market Trends 8.2.4.2 Market Forecast 8.2.5 Australia 8.2.5.1 Market Trends 8.2.5.2 Market Forecast 8.2.6 Indonesia 8.2.6.1 Market Trends 8.2.6.2 Market Forecast 8.2.7 Others 8.2.7.1 Market Trends 8.2.7.2 Market Forecast 8.3 Europe 8.3.1 Germany 8.3.1.1 Market Trends 8.3.1.2 Market Forecast 8.3.2 France 8.3.2.1 Market Trends 8.3.2.2 Market Forecast 8.3.3 United Kingdom 8.3.3.1 Market Trends 8.3.3.2 Market Forecast 8.3.4 Italy 8.3.4.1 Market Trends 8.3.4.2 Market Forecast 8.3.5 Spain 8.3.5.1 Market Trends 8.3.5.2 Market Forecast 8.3.6 Russia 8.3.6.1 Market Trends 8.3.6.2 Market Forecast 8.3.7 Others 8.3.7.1 Market Trends 8.3.7.2 Market Forecast 8.4 Latin America 8.4.1 Brazil 8.4.1.1 Market Trends 8.4.1.2 Market Forecast 8.4.2 Mexico 8.4.2.1 Market Trends 8.4.2.2 Market Forecast 8.4.3 Others 8.4.3.1 Market Trends 8.4.3.2 Market Forecast 8.5 Middle East and Africa 8.5.1 Market Trends 8.5.2 Market Breakup by Country 8.5.3 Market Forecast 9 SWOT Analysis 9.1 Overview 9.2 Strengths 9.3 Weaknesses 9.4 Opportunities 9.5 Threats 10 Value Chain Analysis 11 Porters Five Forces Analysis 11.1 Overview 11.2 Bargaining Power of Buyers 11.3 Bargaining Power of Suppliers 11.4 Degree of Competition 11.5 Threat of New Entrants 11.6 Threat of Substitutes 12 Price Analysis 13 Competitive Landscape 13.1 Market Structure 13.2 Key Players 13.3 Profiles of Key Players 13.3.1 2Morrow Inc. 13.3.1.1 Company Overview 13.3.1.2 Product Portfolio 13.3.2 Canary Health Inc. 13.3.2.1 Company Overview 13.3.2.2 Product Portfolio 13.3.3 Click Therapeutics Inc. 13.3.3.1 Company Overview 13.3.3.2 Product Portfolio 13.3.4 Mango Health Inc. (TrialCard Incorporated) 13.3.4.1 Company Overview 13.3.4.2 Product Portfolio 13.3.5 Noom Health Inc. 13.3.5.1 Company Overview 13.3.5.2 Product Portfolio 13.3.6 Omada Health Inc. 13.3.6.1 Company Overview 13.3.6.2 Product Portfolio 13.3.7 Pear Therapeutics, Inc. 13.3.7.1 Company Overview 13.3.7.2 Product Portfolio 13.3.8 Propeller Health (ResMed) 13.3.8.1 Company Overview 13.3.8.2 Product Portfolio 13.3.9 Teladoc Health Inc. 13.3.9.1 Company Overview 13.3.9.2 Product Portfolio 13.3.10 Voluntis Inc. 13.3.10.1 Company Overview 13.3.10.2 Product Portfolio 13.3.11 WellDoc Inc. 13.3.11.1 Company Overview 13.3.11.2 Product Portfolio
SummaryThe global digital therapeutics market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 22% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.Digital therapeutics (DTx) deliver evidence-based therapeutic interventions to patients. They aid in enhancing the existing medical treatments, providing therapy solutions, and reducing reliance on pharmaceuticals using high-quality software programs. They also prevent, manage and treat physical, mental, and behavioral health and find application in diagnosing conditions like Alzheimer’s disease, type II diabetes, and respiratory disorders, such as asthma, gastrointestinal problems, and chronic obstructive pulmonary disease. At present, there is a significant rise in the demand for DTx as they reduce health care costs and support the overall health of patients. Digital Therapeutics Market Trends: The boosting sales of smart devices like mobile phones and tablets, rising internet penetration and the increasing number of healthcare applications are among the major factors strengthening the growth of the market. DTx finds application in a diverse range of neuroscience indications, such as autism spectrum disorder (ASD), attention deficit hyperactivity disorder (ADHD), depression, schizophrenia, and bipolar disease. Additionally, the rising prevalence of chronic diseases like diabetes and obesity, along with the increasing need for controlling costs of healthcare treatments, are supporting the growth of the market. Furthermore, pharmaceutical companies around the world are investing and engaging in strategic partnerships to expand their product portfolio and market reach. They are also focusing on providing patients with information concerning different conditions and subsequent treatments as well as organizing, tracking, and self-managing their diseases. These initiatives undertaken by pharmaceutical companies are anticipated to impel the growth of the market. Key Market Segmentation: IMARC Group provides an analysis of the key trends in each sub-segment of the global digital therapeutics market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on application and end use. Breakup by Application: Diabetes Obesity CVD CNS Disease Respiratory Diseases Smoking Cessation Others Breakup by End Use: Patients Providers Payers Employers Others Breakup by Region: North America United States Canada Asia-Pacific China Japan India South Korea Australia Indonesia Others Europe Germany France United Kingdom Italy Spain Russia Others Latin America Brazil Mexico Others Middle East and Africa Competitive Landscape: The competitive landscape of the industry has also been examined along with the profiles of the key players being 2Morrow Inc., Canary Health Inc., Click Therapeutics Inc., Mango Health Inc. (TrialCard Incorporated), Noom Health Inc., Omada Health Inc., Pear Therapeutics, Inc., Propeller Health (ResMed), Teladoc Health Inc., Voluntis Inc. and WellDoc Inc. Key Questions Answered in This Report: How has the global digital therapeutics market performed so far and how will it perform in the coming years? What has been the impact of COVID-19 on the global digital therapeutics market? What are the key regional markets? What is the breakup of the market based on the application? What is the breakup of the market based on the end use? What are the various stages in the value chain of the industry? What are the key driving factors and challenges in the industry? What is the structure of the global digital therapeutics market and who are the key players? What is the degree of competition in the industry? Table of Contents1 Preface2 Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends 5 Global Digital Therapeutics Market 5.1 Market Overview 5.2 Market Performance 5.3 Impact of COVID-19 5.4 Market Forecast 6 Market Breakup by Application 6.1 Diabetes 6.1.1 Market Trends 6.1.2 Market Forecast 6.2 Obesity 6.2.1 Market Trends 6.2.2 Market Forecast 6.3 CVD 6.3.1 Market Trends 6.3.2 Market Forecast 6.4 CNS Disease 6.4.1 Market Trends 6.4.2 Market Forecast 6.5 Respiratory Diseases 6.5.1 Market Trends 6.5.2 Market Forecast 6.6 Smoking Cessation 6.6.1 Market Trends 6.6.2 Market Forecast 6.7 Others 6.7.1 Market Trends 6.7.2 Market Forecast 7 Market Breakup by End Use 7.1 Patients 7.1.1 Market Trends 7.1.2 Market Forecast 7.2 Providers 7.2.1 Market Trends 7.2.2 Market Forecast 7.3 Payers 7.3.1 Market Trends 7.3.2 Market Forecast 7.4 Employers 7.4.1 Market Trends 7.4.2 Market Forecast 7.5 Others 7.5.1 Market Trends 7.5.2 Market Forecast 8 Market Breakup by Region 8.1 North America 8.1.1 United States 8.1.1.1 Market Trends 8.1.1.2 Market Forecast 8.1.2 Canada 8.1.2.1 Market Trends 8.1.2.2 Market Forecast 8.2 Asia-Pacific 8.2.1 China 8.2.1.1 Market Trends 8.2.1.2 Market Forecast 8.2.2 Japan 8.2.2.1 Market Trends 8.2.2.2 Market Forecast 8.2.3 India 8.2.3.1 Market Trends 8.2.3.2 Market Forecast 8.2.4 South Korea 8.2.4.1 Market Trends 8.2.4.2 Market Forecast 8.2.5 Australia 8.2.5.1 Market Trends 8.2.5.2 Market Forecast 8.2.6 Indonesia 8.2.6.1 Market Trends 8.2.6.2 Market Forecast 8.2.7 Others 8.2.7.1 Market Trends 8.2.7.2 Market Forecast 8.3 Europe 8.3.1 Germany 8.3.1.1 Market Trends 8.3.1.2 Market Forecast 8.3.2 France 8.3.2.1 Market Trends 8.3.2.2 Market Forecast 8.3.3 United Kingdom 8.3.3.1 Market Trends 8.3.3.2 Market Forecast 8.3.4 Italy 8.3.4.1 Market Trends 8.3.4.2 Market Forecast 8.3.5 Spain 8.3.5.1 Market Trends 8.3.5.2 Market Forecast 8.3.6 Russia 8.3.6.1 Market Trends 8.3.6.2 Market Forecast 8.3.7 Others 8.3.7.1 Market Trends 8.3.7.2 Market Forecast 8.4 Latin America 8.4.1 Brazil 8.4.1.1 Market Trends 8.4.1.2 Market Forecast 8.4.2 Mexico 8.4.2.1 Market Trends 8.4.2.2 Market Forecast 8.4.3 Others 8.4.3.1 Market Trends 8.4.3.2 Market Forecast 8.5 Middle East and Africa 8.5.1 Market Trends 8.5.2 Market Breakup by Country 8.5.3 Market Forecast 9 SWOT Analysis 9.1 Overview 9.2 Strengths 9.3 Weaknesses 9.4 Opportunities 9.5 Threats 10 Value Chain Analysis 11 Porters Five Forces Analysis 11.1 Overview 11.2 Bargaining Power of Buyers 11.3 Bargaining Power of Suppliers 11.4 Degree of Competition 11.5 Threat of New Entrants 11.6 Threat of Substitutes 12 Price Analysis 13 Competitive Landscape 13.1 Market Structure 13.2 Key Players 13.3 Profiles of Key Players 13.3.1 2Morrow Inc. 13.3.1.1 Company Overview 13.3.1.2 Product Portfolio 13.3.2 Canary Health Inc. 13.3.2.1 Company Overview 13.3.2.2 Product Portfolio 13.3.3 Click Therapeutics Inc. 13.3.3.1 Company Overview 13.3.3.2 Product Portfolio 13.3.4 Mango Health Inc. (TrialCard Incorporated) 13.3.4.1 Company Overview 13.3.4.2 Product Portfolio 13.3.5 Noom Health Inc. 13.3.5.1 Company Overview 13.3.5.2 Product Portfolio 13.3.6 Omada Health Inc. 13.3.6.1 Company Overview 13.3.6.2 Product Portfolio 13.3.7 Pear Therapeutics, Inc. 13.3.7.1 Company Overview 13.3.7.2 Product Portfolio 13.3.8 Propeller Health (ResMed) 13.3.8.1 Company Overview 13.3.8.2 Product Portfolio 13.3.9 Teladoc Health Inc. 13.3.9.1 Company Overview 13.3.9.2 Product Portfolio 13.3.10 Voluntis Inc. 13.3.10.1 Company Overview 13.3.10.2 Product Portfolio 13.3.11 WellDoc Inc. 13.3.11.1 Company Overview 13.3.11.2 Product Portfolio
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（その他）の最新刊レポート
IMARC Services Private Limited. 社の最新刊レポート
本レポートと同じKEY WORD（industry）の最新刊レポート
よくあるご質問IMARC Services Private Limited.社はどのような調査会社ですか?インドに調査拠点を持つ調査会社。幅広い分野をカバーしていますがケミカルに特に焦点を当てています。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/09/20 10:26 143.76 円 160.81 円 193.57 円 |
